Ireland
--:--IST
Enrolling by invitation Not applicable

Physical and Psychosocial Outcomes of 16-Week Classroom-Based Morning Exercise Program

NCT07860983 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-10-01
Last updated
2026-10-06

Condition(s) studied

Healthy Children

Investigational drug(s) / intervention(s)

Classroom-Based Morning Exercise Program

Classroom-Based Morning Exercise Program: Exercises generally consist of movements that can be done sitting at a desk or standing next to a desk, and do not require equipment. It includes exercises for warming up, stretching, strengthening, balance and relaxation, lasting 10-15 minutes and suitable for daily use. It starts with a deep breathing exercise, continues with basic strength and flexibility exercises that mobilize the body, and ends with a deep breathing exercise again. Exercises that can be performed both sitting and standing are presented together. During the transitions between movements, small exercises such as "waving the hands" are also included as a break.

Study summary

The overall goal of the project is to enhance the physical and emotional well-being of primary school-aged children by incorporating short exercises-practicable within the classroom setting right at their desks-into their daily routines, thereby supporting their body awareness, flexibility, postural control, focus, and stress-coping skills.

Furthermore, the project aims to instill a habit of morning exercise among school-aged children and to determine the impact of this habit on flexibility, body image, pain, general well-being, and school burnout.

Eligibility

Sex
ALL
Min age
6 Years
Max age
12 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Volunteers who are between the ages of 6 and 12, * Attend schools affiliated with the Kartal District Directorate of National Education, * and-after the purpose of the research and the procedures have been explained to the students and their families-agree to participate on a voluntary basis and sign the informed consent form. Exclusion Criteria: * Children who have any condition preventing them from completing self-report scales during the assessment (inability to understand the forms, physical impairment, lack of literacy skills) Who have sustained an upper or lower extremity injury within the last 6 months, Who have undergone upper or lower extremity surgery within the last 6 months, Who have any soft tissue disease, Who are diagnosed with a serious gastrointestinal, cardiovascular, pulmonary, or hematological system disease following a specialist physician examination Who have known spinal problems such as scoliosis, kyphosis, or kyphoscoliosis Who have been diagnosed with a psychotic disorder, bipolar disorder, or autism spectrum disorder Who have a history of epilepsy or severe head trauma Or who use psychotropic medication will not be included in the project

Primary outcome measure(s)

  • FACES Pain Scale — from enrollment to the end of the program at 16 weeks
    Pain assessment in children will be conducted using the Faces (FACES) Pain Scale. This is a visual scale developed to assess pain intensity, particularly in individuals-such as children-who cannot clearly express themselves verbally (Hicks, von Baeyer et al. 2001). The scale features a total of six facial images, progressing from a happy expression to expressions indicating increasing levels of pain. Children rate their pain by selecting the face that best represents how they feel. Widely used for children aged three and older, this scale is a trusted choice in clinical and field studies due to its ease of understanding and rapid administration. Researchers will show the children the various facial images on the scale and ask them to select the face that best reflects their state, thereby determining the pain score.

Trial sites (1)

FacilityCityRegionStatus
İstanbul Medeniyet Üniversitesi Istanbul Kartal
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07860983 on ClinicalTrials.gov ↗ ← All trials in Turkey